Resultado de búsqueda
Hace 20 horas · El martes, Cantor Fitzgerald inició la cobertura de las acciones de Klaviyo Inc (NYSE: NYSE: KVYO), una empresa reconocida por su plataforma de marketing por correo electrónico, la mejor de su ...
Hace 1 hora · Fitch Ratings - Chicago - 16 Apr 2024: Fitch Ratings has affirmed Cantor Fitzgerald, L.P.'s (Cantor) Long-Term and Short-Term Issuer Default Ratings (IDR) at 'BBB-' and 'F3', respectively. Fitch has also affirmed Cantor's senior unsecured debt rating at 'BBB-'. The Rating Outlook is Stable. Fitch has also taken a separate but equivalent rating ...
Hace 6 horas · Thomas Shemia - Cantor Fitzgerald. Operator. Hello, everyone, and thank you for joining us for Marti's Full Year 2023 Conference Call. Before we begin, ...
Hace 20 horas · Cantor Fitzgerald said it shifted focus to oral ganaxolone (O-GNX), which is progressing in the global Phase 3 TrustTSC study for tuberous sclerosis complex (TSC), and to a second-generation ...
Hace 20 horas · On Tuesday, Cantor Fitzgerald initiated coverage on Klaviyo Inc (NYSE: NYSE:KVYO) stock, a company recognized for its best-in-class email marketing platform, with an Overweight rating and a price target set at $31.00. Klaviyo, which went public at $30 per share, has since experienced relatively ...
Hace 1 hora · Cantor Fitzgerald said it shifted focus to oral ganaxolone (O-GNX), which is progressing in the global Phase 3 TrustTSC study for tuberous sclerosis complex (TSC), and to a second-generation ganaxolone (2G-O-GNX) formulation aimed at enhancing safety, efficacy, and tolerability, potentially enabling less frequent dosing.
Hace 20 horas · 2024-04-16 16:38. On Tuesday, Cantor Fitzgerald adjusted its outlook on Marinus (NASDAQ: MRNS ) Pharmaceuticals ( NASDAQ :MRNS), reducing the price target significantly to $13 from the previous $28 while retaining an Overweight rating on the stock. The adjustment comes with a recalibration of expectations, specifically excluding revenue from ...
